The best solution for patients with little or no options.
Visceral therapeutics is an emerging Canadian biotechnology company harnessing the best-in-class research scientists in biotechnology to provide a unique solution to unmet medical needs in the gastrointestinal (GI) space.
Maximizing the potential of proven therapeutics
We are building a technologically advanced bio-pharmaceutical company that will bridge the patient gap between conventional pharmaceuticals and cannabinoid science.
Maximizing the potential of cannabinoid-based medicines
Visceral is a bio-pharmaceutical company that specializes in the development of novel, cannabinoid-based therapeutics by augmenting the efficacy of safe therapeutics with the synergistic effects of CB-1 and CB-2 receptor activity.
Understanding the Science
Our unique approach to providing safe and effective therapeutics has resulted in a diverse pipeline of products targeting high unmet medical needs.
